CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Short Interest Up 753.2% in November

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) was the recipient of a large growth in short interest in November. As of November 30th, there was short interest totalling 133,100 shares, a growth of 753.2% from the November 15th total of 15,600 shares. Based on an average daily trading volume, of 107,300 shares, the short-interest ratio is currently 1.2 days.

CERo Therapeutics Stock Performance

NASDAQ:CEROW remained flat at $0.01 during trading hours on Wednesday. 155,755 shares of the company’s stock were exchanged, compared to its average volume of 70,585. The stock has a fifty day moving average of $0.01 and a 200-day moving average of $0.02. CERo Therapeutics has a 52 week low of $0.00 and a 52 week high of $0.25.

CERo Therapeutics Company Profile

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.